Publication date: Sep 16, 2026
Background: Liver injury (LI) is frequently observed in patients with COVID-19, particularly in severe forms of disease. However, its prognostic significance remains incompletely defined. Aim: To evaluate the association between LI at admission and clinical outcomes in hospitalized patients with moderate, severe, and critical COVID-19. Methods: This single-centre retrospective cohort study included 816 adults hospitalized with moderate-to-critical COVID-19 at a tertiary care hospital in Romania. LI was defined as elevations ≥ 2cD7 the upper limit of normal (ULN) in alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), or total bilirubin (TB) at admission. Clinical, laboratory, imaging, and outcome data, including intensive care unit (ICU) admission, invasive mechanical ventilation (IMV), and mortality, were analysed. Results: LI was present in 34. 9% of patients. Compared with patients without LI, affected patients more frequently exhibited inflammatory syndrome (98. 7% vs. 95. 2%, p = 0. 017), elevated interleukin-6 (IL-6) levels (65. 3% vs. 44. 3%, p = 0. 007), and extensive pulmonary involvement (>75% on chest computed tomography; 38. 2% vs. 27. 3%, p = 0. 003). They were also more likely to require ICU admission (44. 2% vs. 36. 2%, p = 0. 025) and IMV (30. 9% vs. 23. 5%, p = 0. 011). Seven-day mortality (25. 9% vs. 16. 1%, p = 0. 001) and overall mortality (49. 8% vs. 36. 8%, p
Open Access PDF
| Concepts | Keywords |
|---|---|
| Basel | COVID-19 |
| Laboratory | liver diseases |
| Liver | liver function tests |
| Pandemic | mortality |
| Romania | prognosis |
| SARS-CoV-2 |